Kevin M. Mullins's most recent trade in Wrap Technologies Inc was a trade of 12,730 Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on June 24, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Wrap Technologies Inc | Kevin W. Mullins | Former President and Director | Sale of securities on an exchange or to another person at price $ 2.10 per share. | 24 Jun 2024 | 12,730 | 483,421 (1%) | 0% | 2.1 | 26,733 | Common Stock |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 11 Jun 2024 | 85,093 | 4,650,571 | - | 5.5 | 470,564 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 01 Apr 2024 | 9,688 | 4,735,664 | - | 5.9 | 57,450 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 14 Mar 2024 | 44,540 | 4,745,352 | - | 6.3 | 281,938 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 08 Mar 2024 | 124,826 | 4,700,306 | - | 0 | Common Stock | ||
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 08 Mar 2024 | 89,586 | 4,789,892 | - | 0 | Common Stock | ||
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 01 Mar 2024 | 115,136 | 4,575,480 | - | 8.0 | 923,391 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 01 Dec 2023 | 113,334 | 4,690,616 | - | 6.5 | 741,204 | Common Stock | |
| Wrap Technologies Inc | Kevin W. Mullins | Director, CHIEF EXECUTIVE OFFICER | Other type of transaction at price $ 0.00 per share. | 16 Aug 2023 | 250,000 | 496,151 (1%) | 0% | - | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 06 Jul 2023 | 135,400 | 5,030,616 | - | 8.7 | 1,173,918 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 03 Jul 2023 | 150,000 | 5,166,016 | - | 8.7 | 1,308,000 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 03 Jul 2023 | 54,600 | 5,316,016 | - | 9 | 491,400 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 23 Jun 2023 | 65,832 | 5,370,616 | - | 9.0 | 593,805 | Common Stock | |
| Wrap Technologies Inc | Kevin W. Mullins | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.07 per share. | 30 May 2023 | 20,000 | 246,151 (0%) | 0% | 1.1 | 21,438 | Common Stock |
| Wrap Technologies Inc | Kevin W. Mullins | Director, CEO AND PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.17 per share. | 18 May 2023 | 21,872 | 226,151 (0%) | 0% | 1.2 | 25,490 | Common Stock |
| Wrap Technologies Inc | Kevin W. Mullins | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 64,655 | 264,828 (0%) | 0% | - | Common Stock | |
| Wrap Technologies Inc | Kevin W. Mullins | Director, CEO AND PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. | 24 Apr 2023 | 16,805 | 248,023 (0%) | 0% | 1.2 | 19,948 | Common Stock |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 04 Apr 2023 | 69,734 | 5,436,448 | - | 7.6 | 530,676 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 04 Apr 2023 | 6,399 | 5,506,182 | - | 7.6 | 48,760 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 03 Apr 2023 | 97,266 | 5,512,581 | - | 7.4 | 722,686 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 15 Mar 2023 | 43,705 | 5,609,847 | - | 6.1 | 268,349 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 15 Mar 2023 | 200 | 5,653,552 | - | 6.1 | 1,222 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 14 Mar 2023 | 800 | 5,653,752 | - | 6.1 | 4,888 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 08 Mar 2023 | 122,295 | 5,654,552 | - | 6.1 | 748,445 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 06 Mar 2023 | 192,307 | 5,776,847 | - | 0 | Common Stock | ||
| Wrap Technologies Inc | Kevin W. Mullins | PRESIDENT | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 15 Nov 2022 | 25,000 | 200,173 (0%) | 0% | 2.0 | 50,078 | Common Stock |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 30 Sep 2022 | 82,520 | 5,584,540 | - | 7.0 | 580,116 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 13 Jun 2022 | 78,858 | 5,667,060 | - | 5.3 | 417,947 | Common Stock | |
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 25 Apr 2022 | 76,446 | 5,745,918 | - | 0 | Common Stock | ||
| LifeStance Health Group Inc | Kevin M. Mullins | Chief Development Officer | 20 Apr 2022 | 46,283 | 5,669,472 | - | 10.7 | 494,302 | Common Stock | |
| Wrap Technologies Inc | Kevin W. Mullins | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2022 | 356,747 | 356,747 | - | - | Stock Option (Right to Buy) | |
| Wrap Technologies Inc | Kevin W. Mullins | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2022 | 175,173 | 175,173 (0%) | 0% | - | Common Stock |